XYLAZINE-INDUCED PULMONARY-EDEMA IN RATS

被引:35
作者
AMOUZADEH, HR
SANGIAH, S
QUALLS, CW
COWELL, RL
MAUROMOUSTAKOS, A
机构
[1] OKLAHOMA STATE UNIV,COLL VET MED,DEPT PHYSIOL SCI,STILLWATER,OK 74078
[2] OKLAHOMA STATE UNIV,DEPT VET PATHOL,STILLWATER,OK 74078
[3] UNIV ARKANSAS,AGR STAT LAB,FAYETTEVILLE,AR 72701
关键词
D O I
10.1016/0041-008X(91)90088-V
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inhibitors of cytochrome P450, such as SK&F 525-A, prolong the duration of xylazine-ketamine anesthesia and cause pulmonary edema (PE) and death in rats. To determine the cause of PE, Sprague-Dawley rats were given a single dose of xylazine (21 mg/kg, im) alone or in combination with ketamine (45 mg/kg, im) and/or SK&F 525-A (50 mg/kg, ip) and percentage lung to body weight ( %LW BW) ratios (as an indicator of PE) were compared. The results indicated that xylazine caused PE which was independent of ketamine and was enhanced by SK&F 525-A. Subsequently, it was determined that 42 mg/kg xylazine, im, is an optimal edemagenic dose. Xylazine (42 mg/kg, im) increased the %LW BW ratio as compared to control. Pleural effusion (PLE) of various amounts was observed in 75% of the animals. The pleural fluid to serum protein ratio for xylazine was similar to that obtained for α-naphthylthiourea (5 mg/kg, ip). Extensive serous PLE and alveolar edema with hemorrhage were found at necropsy in xylazine-treated rats. Pretreatment with yohimbine (4.2 mg/kg), prazosin (20 mg/kg), tolazoline (20 mg/kg), yohimbine (4.2 mg/kg) plus prazosin (20 mg/kg), atropine (20 mg/kg), dimethyl sulfoxide (DMSO) (7.8 g/kg), allopurinol (50 mg/kg), superoxide dismutase (20,000 U/kg), catalase (20,000 U/kg), BW755C (50 mg/kg), ibuprofen (50 mg/kg), cystathionine (100 mg/kg) plus taurine (100 mg/kg) did not affect the %LW BW ratio. PLE was increased by yohimbine, yohimbine plus prazosin, and allopurinol, reduced by DMSO, and not changed in other groups. The results indicate that xylazine caused increased-permeability PE characterized by rapid onset, cellular damage and protein-rich pleural fluid. PE may not be mediated by adverse cardiovascular effects of xylazine and oxygen radicals are possibly involved in its etiology. © 1991.
引用
收藏
页码:417 / 427
页数:11
相关论文
共 42 条
[41]   KETAMINE - ITS PHARMACOLOGY AND THERAPEUTIC USES [J].
WHITE, PF ;
WAY, WL ;
TREVOR, AJ .
ANESTHESIOLOGY, 1982, 56 (02) :119-136
[42]  
1985, GUIDE CARE USE LABOR